ArticleRetrovirology2013

A common mechanism of clinical HIV-1 resistance to the CCR5 antagonist maraviroc despite divergent resistance levels and lack of common gp120 resistance mutations.

Michael Roche et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.